Skip to main content

Table 3 Selected single-nucleotide polymorphisms in relation to risk of breast cancer, stratified by vitamin D level

From: SNPs related to vitamin D and breast cancer risk: a case-control study

SNP (proxy for GWAS)

Low vitamin Da

 

High vitamin Da

Allele

Frequency in cases/control subjects (n = 684)

ORb of breast cancer (95% CI)

p Value for interaction

Frequency in cases/control subjects (n = 659)

ORb of breast cancer (95% CI)

rs12239582 (rs12144344)

 CC

127/97

1.00

 

99/89

1.00

 CA

176/168

0.85 (0.59–1.21)

0.73

164/172

0.91 (0.62–1.33)

 AA

60/56

0.83 (0.52–1.34)

0.30

74/61

1.16 (0.72–1.87)

rs705117

 CC

278/226

1.00

 

251/235

1.00

 CT

76/88

0.65 (0.45–0.95)

0.28

84/84

0.87 (0.60–1.27)

 TT

9/7

1.14 (0.41–3.22)

0.36

2/3

0.45 (0.66–3.11)

rs7041

 AA

120/93

1.00

 

141/129

1.00

 AC

169/172

0.70 (0.48–1.00)

0.14

161/147

1.05 (0.74–1.47)

 CC

74/56

1.11 (0.69–1.76)

0.15

35/46

0.65 (0.38–1.11)

rs2282679 (rs17467825)

 GG

174/168

1.00

 

209/188

1.00

 GT

155/123

1.25 (0.89–1.75)

0.16

113/117

0.91 (0.65–1.29)

 TT

33/29

1.21 (0.68–2.16)

0.69

14/15

0.92 (0.42–2.04)

 Missing

1/1

1/2

rs10485165

 TT

267/248

1.00

 

262/239

1.00

 TC

88/65

1.34 (0.91–1.98)

0.08

67/77

0.83 (0.56–1.22)

 CC

8/8

0.94 (0.32–2.78)

0.79

8/6

1.11 (0.36–3.40)

rs198300 (rs156299)

 GG

126/92

1.00

 

110/119

1.00

 GA

184/160

0.82 (0.57–1.18)

0.25

165/154

1.06 (0.74–1.52)

 AA

53/69

0.53 (0.33–0.87)

<0.01

62/49

1.38 (0.85–2.23)

rs4751058

 AA

267/229

1.00

 

235/225

1.00

 AG

89/85

0.91 (0.63–1.329

0.37

96/87

1.06 (0.74–1.52)

 GG

7/7

1.00 (0.33–3.03)

0.42

6/10

0.47 (0.16–1.38)

rs12295888 (rs12287212)

 CC

146/124

1.00

 

157/139

1.00

 CT

169/152

0.94 (0.66–1.33)

0.88

154/148

0.86 (0.61–1.20)

 TT

48/45

1.01 (0.60–1.67)

0.33

26/35

0.65 (0.36–1.17)

rs1007392

 GG

129/102

1.00

 

140/127

1.00

 GA

177/160

0.87 (0.61–1.25)

0.71

159/151

0.91 (0.64–1.29)

 AA

57/58

0.81 (0.50–1.30)

0.98

38/44

0.79 (0.47-1.34)

 Missing

0/1

 

rs2060793 (rs10741657)

 AA

134/112

1.00

 

89/105

1.00

 AG

168/160

0.95 (0.67–1.35)

0.10

174/149

1.35 (0.93–1.97)

 GG

61/49

0.99 (0.61–1.60)

0.44

74/68

1.31 (0.83–2.08)

rs7944926 (rs12785878)

 AA

167/130

1.00

 

180/163

1.00

 AG

158/141

0.88 (0.62–1.24)

0.75

137/135

0.93 (0.66–1.29)

 GG

38/50

0.58 (0.35–0.98)

0.49

20/24

0.78 (0.40–1.51)

rs3829251

 AA

218/184

1.00

 

222/213

1.00

 AG

126/116

0.95 (0.68–1.34)

0.56

110/100

1.07 (0.76–1.51)

 GG

19/21

0.74 (0.37–1.49)

0.62

5/9

0.57 (0.18–1.79)

rs2302190

 CC

236/215

1.00

 

229/237

1.00

 CT

114/97

1.03 (0.73–1.47)

0.49

97/79

1.27 (0.88–1.84)

 TT

12/8

1.36 (0.51–3.60)

0.52

9/4

2.11 (0.61–7.30)

 Missing

1/1

2/2

  1. GWAS Genome-wide association study, SNP Single-nucleotide polymorphism
  2. aLow vs high vitamin D grouped by calendar month
  3. bAdjusted for age at baseline, year of inclusion, level of education, type of occupation, age at menarche, age at first childbirth, exposure to oral contraceptives, exposure to hormone replacement therapy, height, body mass index, alcohol consumption and smoking